14.89
price down icon0.07%   -0.010
after-market アフターアワーズ: 15.08 0.19 +1.28%
loading
前日終値:
$14.90
開ける:
$14.79
24時間の取引高:
3.82M
Relative Volume:
0.64
時価総額:
$7.40B
収益:
$4.45B
当期純損益:
$205.00M
株価収益率:
37.23
EPS:
0.4
ネットキャッシュフロー:
$372.00M
1週間 パフォーマンス:
+2.90%
1か月 パフォーマンス:
+7.82%
6か月 パフォーマンス:
+27.26%
1年 パフォーマンス:
+7.82%
1日の値動き範囲:
Value
$14.68
$14.93
1週間の範囲:
Value
$14.49
$15.14
52週間の値動き範囲:
Value
$8.02
$15.78

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name
名前
Elanco Animal Health Inc
Name
セクター
Healthcare (1164)
Name
電話
877-352-6261
Name
住所
2500 INNOVATION WAY, GREENFIELD
Name
職員
9,450
Name
Twitter
@Elanco
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ELAN's Discussions on Twitter

ELAN を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
ELAN
Elanco Animal Health Inc
14.89 7.19B 4.45B 205.00M 372.00M 0.40
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
155.65 69.92B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.04 47.07B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.90 45.59B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.42 19.32B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
297.68 13.10B 2.99B 1.21B 1.13B 25.06

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-09 開始されました UBS Buy
2024-12-02 開始されました Leerink Partners Market Perform
2024-09-19 ダウングレード Morgan Stanley Overweight → Equal-Weight
2024-01-05 アップグレード Stifel Hold → Buy
2023-12-19 開始されました Jefferies Buy
2023-12-15 アップグレード Morgan Stanley Equal-Weight → Overweight
2023-12-07 開始されました Exane BNP Paribas Outperform
2023-04-20 アップグレード Barclays Equal Weight → Overweight
2022-08-18 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-08-16 ダウングレード JP Morgan Overweight → Neutral
2022-07-21 ダウングレード Goldman Buy → Sell
2022-07-12 開始されました Piper Sandler Neutral
2021-11-18 開始されました Morgan Stanley Overweight
2021-10-28 ダウングレード Stifel Buy → Hold
2021-08-05 再開されました Credit Suisse Outperform
2021-06-15 アップグレード Cleveland Research Underperform → Neutral
2021-05-11 アップグレード Barclays Underweight → Equal Weight
2021-05-11 アップグレード Gabelli & Co Hold → Buy
2021-04-15 開始されました Stifel Buy
2021-03-22 ダウングレード Gabelli & Co Buy → Hold
2021-02-26 アップグレード Credit Suisse Neutral → Outperform
2020-12-09 ダウングレード Argus Buy → Hold
2020-11-09 ダウングレード Barclays Overweight → Underweight
2020-08-20 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-08-13 再開されました Credit Suisse Neutral
2020-08-04 再開されました Goldman Buy
2020-07-27 ダウングレード Cleveland Research Neutral → Underperform
2020-04-02 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-01-10 開始されました Raymond James Mkt Perform
2019-12-19 アップグレード BofA/Merrill Neutral → Buy
2019-11-07 アップグレード Morgan Stanley Equal-Weight → Overweight
2019-09-23 開始されました Barclays Overweight
2019-08-26 ダウングレード BofA/Merrill Buy → Neutral
2019-08-15 アップグレード UBS Sell → Neutral
2019-05-23 開始されました Guggenheim Neutral
2019-03-18 アップグレード BofA/Merrill Neutral → Buy
2019-03-13 再開されました Morgan Stanley Equal-Weight
2019-02-12 開始されました William Blair Mkt Perform
2019-01-23 開始されました UBS Sell
2019-01-15 開始されました Argus Buy
2018-10-15 開始されました Morgan Stanley Equal-Weight
すべてを表示

Elanco Animal Health Inc (ELAN) 最新ニュース

pulisher
Jul 13, 2025

Elanco Confirms Date and Conference Call for Second Quarter 2025 Financial Results Announcement - ETX View

Jul 13, 2025
pulisher
Jul 10, 2025

Neurizon, Elanco sign deal to advance ALS therapy NUZ-001 - ALS News Today

Jul 10, 2025
pulisher
Jul 09, 2025

Elanco gets US Agriculture department nod for TruCan (ELAN:NYSE) - Seeking Alpha

Jul 09, 2025
pulisher
Jul 09, 2025

Elanco's dog flu vaccine gets USDA nod - Reuters

Jul 09, 2025
pulisher
Jul 09, 2025

Elanco receives USDA nod for Trucan Ultra Civ canine flu vaccine - MarketScreener

Jul 09, 2025
pulisher
Jul 09, 2025

Elanco Receives USDA Approval for TruCan™ Ultra CIV H3N2/H3N8 (Canine Influenza Vaccine) Bringing to Market a High Standard of Respiratory Protection - PR Newswire

Jul 09, 2025
pulisher
Jul 08, 2025

Elanco Animal Health (ELAN) Shares Soar 1.94% Amid KBC Group NV Stake Reduction - AInvest

Jul 08, 2025
pulisher
Jul 06, 2025

Levi & Korsinsky Notifies Elanco Animal Health Incorporated Investors of a Class Action Lawsuit and Upcoming DeadlineELAN - ACCESS Newswire

Jul 06, 2025
pulisher
Jul 03, 2025

Elanco in licensing pact with Australia’s Neurizon (ELAN:NYSE) - Seeking Alpha

Jul 03, 2025
pulisher
Jul 02, 2025

Neurizon Enters into Global License with Elanco to Accelerate Commercialisation of NUZ-001 - Nasdaq

Jul 02, 2025
pulisher
Jun 28, 2025

Duff & Phelps Provided a Fairness Opinion to Elanco in Connection with its Agreement to Acquire Bayer's Animal Health Business - Kroll

Jun 28, 2025
pulisher
Jun 26, 2025

Elanco Releases 2024 Impact Report and Introduces New Framework - PR Newswire

Jun 26, 2025
pulisher
Jun 26, 2025

Elanco Animal Health: A Catalyst-Driven Revaluation in Agri-Sciences - AInvest

Jun 26, 2025
pulisher
Jun 18, 2025

Zoetis Stock Is Falling. Why the Animal-Health Company Was Downgraded. - Barron's

Jun 18, 2025
pulisher
Jun 18, 2025

Elanco (ELAN) Gains Attention Amid Competitive Market Shifts | E - GuruFocus

Jun 18, 2025
pulisher
Jun 16, 2025

United States Veterinary Pain Management Market Size, Share & - openPR.com

Jun 16, 2025
pulisher
Jun 14, 2025

Harbor Capital Advisors Inc. Has $9.41 Million Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Jun 14, 2025
pulisher
Jun 13, 2025

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from - GuruFocus

Jun 13, 2025
pulisher
Jun 12, 2025

Elanco (ELAN) Awaits European Approval for Zenrelia in Dogs - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco gains positive EMA opinion for Zenrelia for itching in dogs - Seeking Alpha

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco (ELAN) Awaits EU Approval for Veterinary Drug Zenrelia | ELAN Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco’s dog allergy treatment Zenrelia gets positive EU opinion By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Gets 'Positive Opinion' on Canine Itch Drug From European Medicines Agency - marketscreener.com

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) | ELAN Stock News - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Receives Positive Opinion On Zenrelia From EU's Committee - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) – Company AnnouncementFT.com - Financial Times

Jun 12, 2025
pulisher
Jun 12, 2025

BiomEdit CEO: Next gen designer probiotics will disrupt the animal and human health market - AgFunderNews

Jun 12, 2025
pulisher
Jun 12, 2025

Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP) - PR Newswire

Jun 12, 2025
pulisher
Jun 11, 2025

ELAN Q1 Earnings Call: Innovation and Product Launches Drive Outlook Amid Macro Uncertainty - Yahoo Finance

Jun 11, 2025
pulisher
Jun 11, 2025

Elanco Animal Health Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily

Jun 11, 2025
pulisher
Jun 10, 2025

Dog Owner Defends Tick Meds Suit Against Elanco, Retailers - Law360

Jun 10, 2025
pulisher
Jun 10, 2025

What Makes Elanco Animal Health (ELAN) a New Buy Stock - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Jun 10, 2025
pulisher
Jun 09, 2025

Is the Options Market Predicting a Spike in Elanco Animal Health Stock? - Yahoo Finance

Jun 09, 2025
pulisher
Jun 09, 2025

Veterinary Vaccines Market Set to Surge as Global Demand - openPR.com

Jun 09, 2025
pulisher
Jun 09, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Given Average Rating of “Hold” by Analysts - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Report reveals widespread impact of chronic itch in dogs - Veterinary Practice News

Jun 06, 2025
pulisher
Jun 06, 2025

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief - ACCESS Newswire

Jun 06, 2025
pulisher
Jun 06, 2025

Elanco Animal Health Appoints Robert VanHimbergen as Chief Financial Officer - Pet Age

Jun 06, 2025
pulisher
Jun 05, 2025

Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief | ELAN Stock News - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

Equine Healthcare Market Analysis: Trends, Key Players, - openPR.com

Jun 04, 2025
pulisher
Jun 03, 2025

Animal Depression Medication Market Detailed in New Research Report | Zoetis Inc., Elanco Animal Health - openPR.com

Jun 03, 2025
pulisher
Jun 02, 2025

Ameriprise Financial Inc. Has $1.18 Million Stake in Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

Companion Animal Health Market -Depth Analysis, Future Trends - openPR.com

May 30, 2025
pulisher
May 30, 2025

Veterinary Vaccines Market Size, Share & Forecast 2025-2033 | - openPR.com

May 30, 2025
pulisher
May 30, 2025

Cetera Investment Advisers Purchases 4,553 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - Defense World

May 30, 2025
pulisher
May 29, 2025

Elanco at Stifel Jaws & Paws: Strategic Growth and Innovation By Investing.com - Investing.com Canada

May 29, 2025
pulisher
May 29, 2025

Elanco appoints Robert VanHimbergen as chief financial officer - Feed Strategy

May 29, 2025
pulisher
May 29, 2025

Elanco appoints VanHimbergen as CFO - Feedstuffs

May 29, 2025
pulisher
May 29, 2025

Transcript : Elanco Animal Health Incorporated Presents at Stifel Jaws & Paws Conference 2025, May-29-2025 08 - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Elanco names Robert VanHimbergen as new CFO By Investing.com - Investing.com South Africa

May 29, 2025

Elanco Animal Health Inc (ELAN) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Elanco Animal Health Inc (ELAN) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Kurzius Lawrence Erik
Director
Mar 11 '25
Buy
10.20
10,000
102,000
111,459
HOOVER R DAVID
Director
Mar 05 '25
Buy
10.90
25,000
272,558
210,000
Harrington Michael J
Director
Aug 22 '24
Buy
14.85
3,500
51,974
81,094
Simmons Jeffrey N
PRESIDENT, CEO AND DIRECTOR
Aug 12 '24
Buy
13.01
100,000
1,300,610
145,000
$83.06
price up icon 2.15%
$9.14
price up icon 0.22%
drug_manufacturers_specialty_generic RDY
$14.56
price up icon 0.34%
$135.13
price up icon 1.25%
$297.68
price up icon 0.73%
大文字化:     |  ボリューム (24 時間):